Anthony Hagen
Advertisement
Articles by Anthony Hagen
The FDA will reassess 6 indications for immune checkpoint inhibitors that were granted accelerated approval but failed to prove clinical benefit in confirmatory trials.
Advertisement
Latest Updated Articles
Conference Coverage: European Hematology Association 2021 Virtual CongressPublished: August 17th 2021 | Updated:
- For Staying Power, Diabetes Interventions May Need a Hands-on Element
Published: January 21st 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
Medical Debt Emerges as Risk Factor for Housing Instability
3
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
4
How EHRs Help Identify Diabetes Risk in Families of Adults With Prediabetes
5
